Skip to main content

Short Bowel Syndrome News

FDA Approves Gattex (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)

Lexington, MA, May 17, 2019 – Takeda Pharmaceuticals, U.S.A., Inc. (“Takeda”), announced today that the U.S. Food and Drug Administration (FDA) approved extending the indication of Gattex (tedu...

FDA Approves Gattex to Treat Short Bowel Syndrome

December 21, 2012 – The U.S. Food and Drug Administration today approved Gattex (teduglutide) to treat adults with short bowel syndrome (SBS) who need additional nutrition from intravenous feeding...

Ask a question

To post your own question to this support group, sign in or create an account.